Hung Chin-Sheng, Director and Chief Medical Officer of SL Science Holding Ltd, filed an initial statement of beneficial ownership on November 6, 2026, disclosing no securities beneficially owned as of the event date of November 1, 2026.

Key Highlights

  • Reporting person: Hung Chin-Sheng, identified in the filing as both Director and Chief Medical Officer of SL Science Holding Ltd (NASDAQ:SLBT).
  • Event date: The date of event requiring the statement is listed as November 1, 2026.
  • Filing date: The form was signed and filed on November 6, 2026.
  • No securities held: The filing states, "No securities are beneficially owned," with both Table I (non-derivative securities) and Table II (derivative securities) left blank.
  • Filing type: This is an initial statement, not an amendment, according to the filing.

Hung Chin-Sheng's Initial Ownership Statement at SL Science Holding Ltd

According to the filing, Hung Chin-Sheng submitted a Form 3 Initial Statement of Beneficial Ownership of Securities to the U.S. Securities and Exchange Commission on November 6, 2026. The event requiring the statement is dated November 1, 2026. The filing identifies Hung Chin-Sheng as holding the dual roles of Director and Chief Medical Officer at SL Science Holding Ltd, which trades on NASDAQ under the ticker SLBT.

The filing discloses no beneficial ownership of any securities, either direct or indirect. Table I, covering non-derivative securities, contains no entries, and Table II, covering derivative securities such as puts, calls, warrants, options, and convertible securities, is also blank. The explanation provided in the filing states: "No securities are beneficially owned." The form was filed by one reporting person, as indicated by the checked box for individual filing.

The reporting person's address is listed as C/O 11th Floor, No. 479 Chongyang Road, Nangang District, Taipei 115010, Taiwan. The form was signed as "/s/ Chin-Sheng Hung" and dated November 6, 2026.

What Was Disclosed

Hung Chin-Sheng, Director and Chief Medical Officer of SL Science Holding Ltd (NASDAQ:SLBT), filed an initial beneficial ownership statement dated November 1, 2026, disclosing no direct or indirect holdings in any class of the company's securities.